HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alejandro A Diaz Selected Research

Fibrosis (Cirrhosis)

3/2012Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alejandro A Diaz Research Topics

Disease

26Chronic Obstructive Pulmonary Disease (COPD)
01/2024 - 03/2012
12Emphysema
01/2023 - 08/2010
4Dyspnea (Shortness of Breath)
12/2023 - 07/2013
3Bronchiectasis
12/2023 - 10/2022
3Chronic Bronchitis
01/2023 - 02/2017
3Pneumonia (Pneumonitis)
01/2021 - 03/2012
2Obstructive Lung Diseases (Obstructive Lung Disease)
10/2020 - 11/2019
2Inflammation (Inflammations)
01/2017 - 10/2014
1Airway Obstruction (Choking)
01/2024
1Lung Neoplasms (Lung Cancer)
01/2023
1Asthma (Bronchial Asthma)
01/2023
1Cystic Fibrosis (Mucoviscidosis)
01/2022
1Bacterial Pneumonia
01/2021
1Myocardial Infarction
01/2021
1Bacterial Infections (Bacterial Infection)
01/2021
1Infections
01/2021
1Chronic Disease (Chronic Diseases)
10/2020
1Disease Progression
01/2018
1Lung Diseases (Lung Disease)
01/2018
1Vascular Diseases (Vascular Disease)
09/2017
1Cardiovascular Diseases (Cardiovascular Disease)
09/2015
1Obesity
01/2015
1Hypertension (High Blood Pressure)
01/2015
1Pneumococcal Pneumonia
01/2013
1Coronary Artery Disease (Coronary Atherosclerosis)
03/2012
1Pulmonary Fibrosis (Fibrosing Alveolitis)
03/2012
1Interstitial Lung Diseases (Interstitial Lung Disease)
03/2012
1Fibrosis (Cirrhosis)
03/2012
1Lung Injury
03/2012

Drug/Important Bio-Agent (IBA)

12GoldIBA
12/2023 - 03/2012
8Biomarkers (Surrogate Marker)IBA
01/2022 - 03/2014
4SmokeIBA
12/2023 - 09/2017
3CalciumIBA
01/2021 - 09/2015
2Anti-Bacterial Agents (Antibiotics)IBA
01/2021 - 02/2017
2Carbon MonoxideIBA
01/2018 - 07/2013
2CholesterolIBA
01/2015 - 03/2012
1Complement System Proteins (Complement)IBA
11/2023
1InterferonsIBA
01/2023
1vascular factorIBA
10/2022
1Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA
01/2022
1Proteins (Proteins, Gene)FDA Link
01/2021
1Blood Proteins (Serum Proteins)IBA
01/2021
1Phenobarbital (Luminal)FDA Link
01/2020
1poly(N-p-vinylbenzyl-maltonamide)IBA
10/2018
1Peptide Hydrolases (Proteases)FDA Link
01/2018
1Protease Inhibitors (Protease Inhibitor)IBA
01/2018
1SteroidsIBA
02/2017
1CollagenIBA
01/2017
1ElastinIBA
01/2017
1Bronchodilator Agents (Bronchodilators)IBA
11/2014
1AntigensIBA
01/2013
1Oxidoreductases (Dehydrogenase)IBA
03/2012
13-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA
03/2012
1Bleomycin (Blenoxane)FDA LinkGeneric
03/2012
1InflammasomesIBA
03/2012
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
03/2012
1indium-bleomycinIBA
03/2012
1cyclo(Arg-Pro) (CI 4)IBA
03/2011
1antineoplaston A10 (A 10)IBA
08/2010

Therapy/Procedure

2Therapeutics
01/2021 - 10/2020
1Nebulizers and Vaporizers (Inhaler)
01/2023
1Precision Medicine
01/2022
1Drug Tapering
01/2019
1Pneumonectomy (Lung Volume Reduction)
01/2015